We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

WWW:NYSEWolverine World Wide, Inc. Analysis

Data as of 2026-08-31 - not real-time

$19.73

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Wolverine World Wide, Inc. is priced at $19.73 and its moving averages line up in bullish order, the shorter sitting above the longer. Over a rolling month the price has gained 6.0%. RSI sits at 50.4, which reads as neutral, and MACD momentum is bearish. The recent range runs from support at $17.69 up to resistance at $21.47.
On valuation the read is undervalued — an earnings multiple of 15.4, absent a reliable peer benchmark. Sell-side targets cluster 23.2% above the current quote. Revenue is growing at 6.8% on a 5.5% profit margin. The 1.97% dividend yield looks covered by current payout levels.
The composite risk read is 9/10, putting it in high territory. With 30-day volatility of 59.3%, a beta of 1.15 and a maximum drawdown of 54.2%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on buy — conviction 5 out of 10.

Top Market Events

Wolverine World Wide Inc. NYSE:WWW shares climbed 8% in Thursday premarket trading after the footwear and apparel...Seeking Alpha18dWolverine World Wide signals FY2026 EPS of $1.Seeking Alpha18dWolverine World Wide, Inc.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 17.62
  • MACD momentum is negative

Medium Term

1–3 years
Positive
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 17.62
  • Analyst targets imply +23.2% versus the current price

Long Term

> 3 years
Positive
Model confidence: 5/10

Key Factors

  • Analyst targets imply +23.2% versus the current price
  • P/E ratio of 15.4
  • Return on equity of 27.6%

Key Metrics & Analysis

Financial Health

Revenue Growth6.80%
Profit Margin5.55%
P/E Ratio15.4
ROE27.65%
ROA6.19%
Debt/Equity159.14
Op. Cash Flow$182.6M
Free Cash Flow$131.3M

Technical Analysis

TrendBullish
RSI50.4
Support$17.69
Resistance$21.47
MA 20$19.81
MA 50$18.77
MA 200$17.62
MACDBearish
VolumeDecreasing
Fear & Greed Index94.79

Valuation

Fair Value$20.05
Target Price$24.30
Upside/Downside23.16%
GradeUndervalued
TypeBlend
Dividend Yield1.97%

Risk Assessment

Beta1.15
Volatility59.28%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.